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ABSTRACT  A  polyclonal  antiserum  to  a  microtubule-associated  protein  (MAP) from  mouse 
neuroblastoma  cells  (MAP 4) was used  to examine the distribution  of this protein  in mouse 
tissues.  Immunoblots  of neuroblastoma  cell  microtubule  protein  preparations  demonstrated 
that the antiserum  reacted with a triplet of proteins at 215,000-240,000  mol wt. Antibodies 
affinity purified from any of the bands showed cross-reaction with the other bands,  indicating 
these polypeptides were all immunologically  related. Antibodies specific to MAP 4 decorated 
microtubules in cultured murine cells fixed with glutaraldehyde, and diffuse staining was seen 
following treatment of cells  with nocodazole.  The antiserum  reacted with MAP 4  in extracts 
of brain, heart, liver, and lung from adult mouse; the triplet in brain was more closely spaced 
than in the other tissues or neuroblastoma cells.  In kidney, spleen, and stomach, only a single 
band (band 4) was labeled; this band was immunologically  related to the triplet and was also 
present  in  all  tissues  positive  for the  triplet.  Skeletal  muscle,  sperm,  and  peripheral  blood 
contained  no  reactive  polypeptides.  After  taxol-induced  polymerization,  the  MAP 4  triplet 
was preferentially  associated  with  the  microtubule  pellet whereas  band  4  remained  in  the 
supernatant.  These data indicate that there  is tissue  specificity  in the distribution  of MAP 4, 
and that some tissues contain a polypeptide  related to MAP 4 (band 4) that does not bind to 
microtubules in vitro. 
The existence of proteins that co-assembled with tubulin (8, 
23,  32) and that decorated the surface of microtubules (13, 
20,  22,  33,  38,  43)  was initially derived from studies with 
brain tissue. However, most work on the distribution of these 
microtubule-associated proteins (MAP) ~  has been carried out 
with cultured cells. Studies in which polyclonal antisera raised 
against high molecular weight MAP (MAP 1 and MAP 2) (9, 
10,  12,  29-31)  or low molecular weight MAP (tau) (9-11) 
were found to label microtubule networks in non-neuronal 
cells suggested that proteins homologous to the brain MAP 
were  widely  distributed  among  cell  types.  More  recently, 
monoclonal antibodies to a subspecies of brain MAP 1, MAP 
1A, have been shown to react with various continuous cell 
lines (4), whereas monoclonal antibodies to MAP 2 have been 
found to have a more restricted distribution (18,  19). While 
all of these studies indicate that MAP similar to those found 
in brain exist in continuously growing cultures,  little is yet 
known about the occurrence of any of these proteins in non- 
neuronal tissues. 
MAP  distinct  from those  of brain  were  identified  when 
~  Abbreviations  used  in  this  paper."  MAP, microtubule-associated 
proteins; PMSF, phenylmethylsulfonyl fluoride; TAME, Na-p-tosyl- 
L-arginine methyl ester. 
clonal cell lines were used  as sources of microtubules. For 
example,  in  vitro  assembly of microtubules  demonstrated 
major MAP of 125,000  and 210,000 mol wt in HeLa cells (5, 
39,  40) and 215  mol wt in mouse neuroblastoma cells (26). 
By  using  selective  solubilization,  major  MAP  species  of 
-200,000-220,000,  80,000,  and 69,000 mol wt were found 
in a  variety of cell types (14).  Although the 69,000-mol-wt 
MAP from cells showed peptides in common with tau proteins 
from brain (14), the high molecular weight species differed in 
molecular weight from brain MAP  1 or 2.  In addition,  the 
proteins in the 200,000-220,000-mol-wt range showed differ- 
ences in  molecular weight between rodent  and human  cell 
lines. 
Although the studies cited above have shown that a number 
of MAP can be identified in cultured cells, the occurrence of 
any these proteins in primary tissues other than brain has not 
yet been investigated. Our previous work indicated that the 
MAP we had  identified in  mouse neuroblastoma cells was 
present in very low amounts in cells (27),  and we therefore 
raised antibodies to use as probes for the localization of this 
protein. As described subsequently, this MAP, originally iden- 
tified as having a molecular weight of 215,000,  is actually a 
complex of related polypeptides ranging in molecular weight 
between 215,000  and 240,000,  this complex will be referred 
to as MAP 4. This paper describes the complexity of MAP 4 
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is restricted to a subset of these tissues. 
MATERIALS AND  METHODS 
Antibody Preparations 
A polyclonal antiserum was produced in a New Zealand White rabbit using 
microtubule protein fractions (I-LP; 1 mg total for all injections) obtained from 
differentiated neuroblastoma cells by four cycles of  D20-induced assembly (27). 
Samples were  resuspended  in  PBS and sonicated  with an equal  volume of 
complete Freund's adjuvant and the rabbit was injected subcutaneously with a 
total of 1.4 ml of immunogen, 0.7 ml in each of two sites on the back.  1 wk 
later, an additional  1.4 ml of immunogen was injected. The rabbit was bled 2 
wk after  the  second  injection,  and then every 3--4 d  for  12  wk.  For some 
experiments,  antibodies  to the  proteins  of interest  (see Results) were affinity 
purified from diazotized paper blots (24), and were used to reprobe blots or for 
immunostaining.  Absorption of the whole antiserum with purified tubulin had 
no effect on the labeling  patterns  on blots  or cells. Tubulin antisera  were 
prepared as described previously (37). 
Immunoblots 
Protein  samples were resolved by SDS PAGE (4--6, 7, or 8% acrylamide 
gels) (21) and  then electrophoretically  transferred  to diazotized  paper blots 
paper (34) or nitrocellulose (modified from Towbin et at. 135] by inclusion of 
0.1% SDS [ 15] in the blotting buffer). Under the conditions  used, proteins of 
all molecular weights transferred efficiently to the blots. Blots were incubated 
with antibodies  for  10-18 h at room temperature,  and antibody  binding was 
detected either with iodinated protein A (2 x  105 or 106 cpm/ml) and autora- 
diography, or with goat anti-rabbit  serum coupled to peroxidase and reacted 
with 4-chloro-l-naphthol  or O-dianisidine. Gels were stained for protein  with 
Coomassie Blue, and blots were stained with amido black. 
Immunomicroscopy 
For indirect  immunofluorescence,  cells that had been plated on coverslips 
were fixed for 10 min at room temperature  with 1.0% glutaraldehyde in 0.1 M 
PIPES, pH 6.9. Cells were rinsed in 0.I M PIPES, and extracted with 0.5-1% 
Triton-X  100  in 0.1  M  PIPES for 30  min (three changes). Covet'slips were 
rinsed in PBS, reduced with 1 mg/ml NaBtL in three  parts 0.1  M PIPES/I 
part 99% EtOH for 15 min (five changes), rinsed, and then incubated with 1% 
BSA in PBS or Tris-buffered saline, pH 7.6, for 30 min at room temperature. 
Coverslips were then split in two, and each half  was incubated with blot-purified 
antibodies to MAP 4 or tubulin antiserum for 30 min at 37"C. After rinsing, 
coverslips were incubated with fluorochrome-conjugated goat anti-rabbit serum 
(Miles Laboratories Inc., Elkart, IN), rinsed, and mounted in Gelvatol. Samples 
were photographed  using a Zeiss universal microscope equipped with epifluo- 
rescence optics. 
Molecular Weight Determination 
7 or 4-6% gradient gels were prepared which contained  microtubule  prep- 
arations  from neuroblastoma cells or  mouse tissues. The  migration  of the 
proteins  of interest  were compared with those of MAP 2 (270,000 mol wt), 
alpha-spectrin (245,000 mol wt), beta-spectrin (220,000 tool wt), myosin heavy 
chain (205,000 tool wt), and B-galactosidase (116,000 tool wt), and the molec- 
ular weights were estimated from a semi-log standard plot of denatured  molec- 
ular weights relative to migrated distance. 
RESULTS 
Immunoblotting was used initially to characterize the  anti- 
serum raised to four-cycled microtubule protein preparations 
(27) from mouse neuroblastoma cells. As shown in the Coo- 
massie Blue-stained gel in Fig.  1  A, a microtubule pellet (lane 
1) prepared by taxol-ariven assembly from neuroblastoma cell 
extracts contained a number of protein bands in addition to 
tubulin. Immunoblot analysis (Fig.  1  B, lane 1) of this sample 
demonstrated that the MAP 4 antiserum reacted with a triplet 
of bands; similar results have been obtained with immuno- 
blots of cycled microtubule protein preparations from neu- 
roblastoma cells (26).  The presence of all three polypeptides 
with the microtubule pellet indicated that all of these proteins 
were MAP. The mobility of the reactive species was between 
215,000  and  240,000  mol  wt;  this  is  the  same  range  of 
molecular weight as the dominant neuroblastoma MAP. This 
MAP, originally designated as 215,000 tool wt (27),  has been 
shown  here  to  be  similar  in  mobility  to  alpha-spectrin 
(240,000 mol wt, see Fig. 3 for comparison), and will be called 
MAP 4.  No reaction was observed in the region of tubulin, 
Sample Preparations 
MOUSE TISSUES:  Mice were killed by cervical dislocation,  and organs 
were removed and placed on ice. Organs were immediately  homogenized  in 
0.1 M PIPES, pH 6.9, 0.1 mM MgCI2, 1.0 mM EGTA, 2.5 mM GTP,  1.0 mM 
phenylmethylsulfonyl fluoride (PMSF) (PMEG) (ratio of 1.0 g wet wt/l.5 ml 
buffer). For portions of this study,  10 mM Na-p-tosyl-L-arginine methyl ester 
(TAME) and 0.1 mg/ml trypsin inhibitor were also included in the PMEG. We 
prepared extracts by centrifugation  for 40 min at 38,000 g and by centrifuging 
the resultant  supernatants  for 90 min at 40,000 rpm (Beckman type 65 rotor, 
Beckman Instruments, Inc., Palo ARo, CA). Mouse erythrocytes were washed 
three times in cold PBS with  1 mM PMSF. Ghosts were prepared by washing 
the erythrocytes three times with Buffer H (17). The erythrocyte  membranes 
were collected with 10-rain spins at 38,000 g between each wash. 
MICROTUBULE  AND  MAP  PREPARATIONS;  Extracts were prepared 
and  microtubules  were  polymerized  from neuroblastoma  cells using either 
020- (27) or taxol- (36) driven  assembly. Microtubules  from mouse tissues 
were obtained using the taxol-procedure of  Vallce (36), except that 20 t~M taxol 
was used for brain extracts, and 40 gM taxol  for all other organs or tissues. 
After sedimentation  of the microtubules, the supernatant (designated HSr) was 
removed, and the pellet (HPT) was washed with PMEG containing 20 pM taxol 
and recentrifuged. Brain microtubules were also prepared by cycles of assembly 
(28). We prepared  thermostable  MAP (16) by boiling microtubule  fractions 
resuspeuded in 0. l M PIPES, 0.2 mM MgC12, 2 mM EGTA, 2.5 mM GTP, 2.2 
mM dithiothreitol,  l  mM  PMSF,  0.75 M  NaCl,  pH  6.9, for 5  rain,  and 
centrifuging the boiled sample at 14,000 g for 15 min. 
FIGURE  1  Preparation and immunoblotting of thermostable MAP. 
(A) 8% acrylamide gel stained with Coomassie Blue of microtubule 
pellet (HPT) prepared from neuroblastoma extracts by taxol-driven 
assembly (lane 1); pellet fraction after boiling and centrifugation of 
fraction shown in lane I  (lane 2); supernatant  fraction after boiling 
and centrifugation of fraction shown in lane 1 (lane 3). (B) Immu- 
noblot  of fractions shown in A, probed with whole MAP 4 antiserum. 
Note that the antiserum reacts with a triplet of bands (MAP 4A, 4B, 
and 4C) and that all of these bands are present in the thermostable 
fraction (lane 3). 
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served protein. 
The relationship of the triplet of polypeptides detected by 
immunoblotting was analyzed in neuroblastoma extracts. 4- 
6% gradient gels were used to achieve greater separation of 
the reactive species (e.g.,  Fig.  3 C) and antibodies specific to 
each of these bands were prepared by affinity purification of 
the antibodies from individual bands on blots (24). Antibodies 
eluted from any of the bands reacted with all other bands in 
this  region  and  indicated  that  these  were immunologically 
related.  These  bands  were  also  present  in  neuroblastoma 
extracts prepared under conditions where proteolysis would 
have  been  favored  (no  protease  inhibitors,  incubation  of 
homogenates for  1 or 2  h  at 0* or 37"C),  as well as under 
conditions that minimized in vitro proteolysis (protease in- 
hibitors,  immediate boiling of cells in  SDS  sample buffer). 
These data (also see Fig. 4) suggested that all of the polypep- 
tides recognized by the MAP 4 serum were present in vivo. 
In addition to sharing antigenic determinants and the ability 
to co-assemble with microtubules, the three polypeptides of 
the MAP 4  complex were also similar in remaining soluble 
after  boiling.  An  aliquot  of  the  microtubule  preparation 
shown in Fig.  1A was boiled, and the resultant supematant 
and  pellet were analyzed by immunoblotting.  As shown in 
Fig.  1  B, all three of the polypeptides present in the microtu- 
bule fraction (lane 1) were recovered in the supernatant after 
boiling (lane 3). Thus, like MAP 2 (16),  HeLa 210,000-mol- 
wt MAP (41), and tau (8), the proteins of the MAP 4 complex 
appear to  be thermostable.  To  remain  consistent  with  the 
nomenclature recently given to MAP 1 and MAP 2 subspecies 
(3),  we designate the thermostable species reacting with the 
MAP 4 antisera MAP 4A, MAP 4B, and MAP 4C in order of 
increasing mobility on SDS gels. 
Using antibodies affinity purified from the MAP 4 triplet, 
immunofluorescent staining was used to assess whether this 
protein  was  also  associated  with  microtubules  in  situ.  As 
shown in Fig. 2 A, MAP 4-specific antibodies showed a pattern 
in  3T3 cells similar to that seen with the tubulin antiserum 
(Fig. 2 B). Following treatments that disrupted microtubules, 
diffuse  intracellular  staining  was  observed  with  either  the 
purified antibodies to MAP 4 (Fig. 2 C) or tubulin antiserum 
(Fig.  2D).  Thus,  unlike  MAP 2,  which  has been shown  to 
redistribute with intermediate filaments upon dissolution of 
microtubules (2),  MAP 4  appears to diffuse throughout the 
cytoplasm. 
While the  preceding data demonstrated that the  MAP 4 
antibodies  reacted  with  MAP  in  cultured  murine  cells,  a 
primary goal was to establish whether this MAP was present 
in  mouse tissues.  Therefore,  we  prepared immunoblots of 
extracts from various mouse tissues and  probed them with 
the  antiserum.  Fig.  3  shows that the  antiserum reacts with 
polypeptides in  heart,  liver,  and  lung similar in  molecular 
weight to those in neuroblastoma extracts. Brain also shows 
a similar pattern, although the triplet is more closely spaced 
and  MAP 4C  is  not  as prominent as in  neuroblastoma or 
other tissues.  No triplet is present in kidney, spleen, or stom- 
ach. However, these tissues, as well as brain, heart, liver, and 
lung, contain a lower molecular weight polypeptide (band 4) 
that reacts with the antiserum (see below). Several prepara- 
tions contained neither the triplet nor band 4; these included 
skeletal  muscle  from thigh,  mouse erythrocyte membranes 
(Fig. 3), whole peripheral blood, and isolated sperm (data not 
shown). Thus, the complexity and extent of cross-reaction of 
polypeptides with the MAP 4 antiserum varied depending on 
tissue origin. 
Organ  homogenates  prepared  under  various  conditions 
were  examined  to  determine  whether  the  diversity  in  the 
patterns seen by immunoblotting might be the  result of in 
vitro proteolysis. Samples were prepared from brain homog- 
enized in boiling sample buffer, or from brain homogenates 
incubated at 0* or 37"C in the presence or absence of PMSF, 
TAME, and trypsin inhibitor. As shown in Fig. 4, immuno- 
blots demonstrate that the polypeptide patterns are identical 
under all conditions tested. Similar results were obtained in 
examining other tissue samples; MAP 4B, MAP 4C, and band 
4 were present in tissues homogenized immediately in boiling 
sample buffer, and showed no change on prolonged incuba- 
tion, suggesting that these bands exist in vivo. 
In  addition  to  the  MAP  4  triplet,  the  whole  antiserum 
labeled two other bands in brain extract, one additional band 
in  neuroblastoma extract,  and  one doublet in  heart extract 
(see  Fig.  3).  The  two  bands  labeled  in  brain  extract  co- 
migrated with MAP  1 and MAP 2 from mouse brain micro- 
tubules obtained by taxol-driven assembly (see  Fig.  7).  The 
cross-reactive species in  neuroblastoma extract co-migrated 
with  a  protein,  originally  identified  as  having  a  molecular 
FIGURE  2  Indirect  immunofluorescence  staining  with  MAP  4  and  tubulin  antibodies.  3T3  cells  were  labeled  by  indirect 
immunofluorescence using either antibodies affinity purified from MAP 4  in blots of neuroblastoma HPT  (A and C) or tubulin 
antiserum (B and D). 3T3 cells in C and D were treated with 60 ng/ml nocodazole for 3 h before labeling. (A and B) x  500;  (C 
and D) x  214. 
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immunoblot (A').  (B and B') Tissue extracts; 7% gel (B) and corresponding immunoblot (B'). (C and C') Erythrocyte ghosts and 
brain extract; 4-6% gradient gel (C) and corresponding immunoblot (C'). Nb, neuroblastoma; Br, brain; He, heart; Ki, kidney; Li, 
liver; Lu, lung; Sp, spleen; Sk, skeletal muscle; St, stomach; E, erythrocyte ghosts. Whole MAP 4 antiserum reacts with a molecular 
weight species identical to MAP 4 in only a subset of mouse tissues. Band  4 is common to all organs except skeletal muscle. Note 
that the antiserum does not react with any polypeptides in mouse erythrocyte membranes, and the position of migration of the 
triplet is between that of ~- (245,000 mol wt) and/~- (220,000 mol wt) spectrin.  Molecular weight markers (x 10-3), as defined in 
Materials and Methods, are indicated. Bracket, MAP 4A, 4B, 4C; dash, band 4. 
FIGURE 4  Effect of 37°C incubation on MAP 4 in brain homoge- 
nates. (lane 1) Whole brain sonicated in boiling sample buffer; (lane 
2) whole brain incubated at 370C, 0.5 h, then sonicated  in boiling 
sample buffer;  (lane 3) brain homogenate prepared without inhibi- 
tors present, incubated at 0°C, 0.5 h; (lane 4) sample as in lane 3, 
incubated at 37°C, 0.5  h; (lane 5) brain homogenate prepared in 
the presence of 1 mM PMSF, 0.1  mg/ml trypsin  inhibitor, and 10 
mM TAME, incubated at 0°C, 0.5 h; (lane 6) sample as in lane 5, 
incubated at  370C,  0.5  h.  Samples were  run  in  a  7%  gel  and 
immunoblots were incubated with whole MAP 4 antiserum.  Prep- 
aration of brain  homogenates under conditions that would accel- 
erate proteolysis (lanes 2 and 4) does not affect the composition of 
the MAP 4 complex. Two dots, MAP 1  ; bracket, MAP 4. 
weight of 310,000, that associates with microtubules through 
three cycles of assembly (27).  Although  present in  blots of 
extracts, this protein was not consistently detected in immu- 
noblots  of  microtubule  preparations  from  neuroblastoma 
cells.  Antibodies  were  affinity purified  from the  region  of 
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FIGURE 5  Immunoblots probed with  antibodies affinity purified 
from MAP 4 region and MAP 1 region. Neuroblastoma, brain, and 
heart extract were electrophoresed on a 7% gel, blotted, and then 
incubated with (A) whole MAP 4 antiserum,  (B) antibodies affinity 
purified from the MAP 4 band, (C) antibodies affinity purified from 
the MAP 1 region.  Nb,  neuroblastoma; Br,  brain;  He, heart. Anti- 
bodies eluted from MAP 4 (all three bands) reacted only with MAP 
4  in  each  extract (B). Affinity-purified MAP  1 antibodies reacted 
with MAP 1 in brain and with a higher molecular weight protein 
(>350,000 mol wt of MAP 1) in neuroblastoma extract (C). The low 
molecular weight bands labeled with whole serum  in neuroblas- 
toma or brain extract are present in the preimmune serum, and are 
not related to the immunogen. Two dots, MAP 1; arrowhead, MAP 
4; dash, band 4. 
MAP  1 and MAP 4 and used to investigate the relationship 
of these antigenic species on blots of neuroblastoma, heart, 
and brain extract. Fig. 5 shows that the antibodies eluted from the MAP 4  complex (seen in this autoradiogram as a  fused 
band) react exclusively with the triplet and band 4  in  each 
extract (Fig.  5 B).  Antibodies eluted from MAP  1 react with 
MAP  1 in brain and the high molecular weight polypeptide 
in neuroblastoma extract (Fig. 5 C). These data indicate these 
proteins are immunologically related, although the neuroblas- 
toma protein  has a  higher  molecular weight than  MAP  1. 
FIGURE 6  Immunoblots of tissue extracts probed with antibodies 
affinity purified from MAP 4 triplet and from band 4.  Each organ 
extract was electrophoresed on a 7% gel, blotted, and then incu- 
bated with (A) whole MAP 4 antiserum,  (B) antibodies eluted from 
the MAP 4 triplet, or (C) antibodies eluted from band 4. Lu,  lung, 
Ki,  kidney. Antibodies eluted from MAP 4 label both MAP 4 and 
band 4 in lung and band 4 in kidney. Conversely, antibodies eluted 
from band 4  label both MAP 4 and band 4. Arrowhead, MAP 4; 
dash, band 4. 
Sufficient antibodies have  not  yet been  obtained  from the 
area  of MAP  2  to  assess the  relatedness  of this protein  to 
other proteins in these extracts. However, as indicated by lack 
of reaction  of affinity-purified antibodies  from  MAP  1  or 
MAP  4  with  each  other  or  with  MAP  2,  the  three  MAP 
detected in  brain  extracts all appear to  be distinct  entities. 
Antibodies eluted  from a  control  area  of diazotized  paper 
blots showed no labeling. 
Similar  experiments  were  carded  out  to  determine  the 
relation of band 4 to the MAP 4 triplet. Antibodies from the 
triplet or band 4  were affinity purified from blots of organ 
extracts,  and  were used  to  probe blots of kidney and  lung 
extracts. Fig. 6 shows that antibodies eluted from the MAP 4 
complex will  label the  triplet in  lung as well as band  4  in 
kidney. Antibodies eluted from band 4 will label only band 4 
in blots of kidney extracts but will label the MAP 4 complex 
and band 4  in organs that possess the MAP 4 triplet. These 
data indicate that MAP 4A, 4B, and 4C and band 4 all share 
antigenic determinants. 
MAP 4A, B, and C had been identified as MAP from the 
in vitro polymerization studies using neuroblastoma cell ex- 
tracts, but we also wished to examine whether these MAP and 
band 4 co-polymerized with microtubules from tissue extracts. 
As shown  in  Fig.  7,  microtubule pellets (HPT)  enriched  in 
tubulin  could  be  obtained  from  tissue  extracts  using  the 
assembly promoting drug,  taxol; gels  of the  corresponding 
supematants (HST) were essentially identical in composition 
to the extracts shown in Fig.  3, except for the diminution of 
tubulin. As shown in the blots (Fig. 7, A and B), microtubule 
pellets from brain,  heart,  liver, and  lung extracts contained 
MAP 4A,  and varying amounts of 4B and C, whereas only 
small amounts of any of these bands remained in  the HST 
fraction (compare immunoblots of HPT and  HSt of brain, 
heart,  liver,  and  lung  in  Fig.  7).  In  contrast,  microtubules 
prepared from kidney and  spleen  showed no reaction with 
the MAP 4 antiserum. Band 4, previously identified in extracts 
of these tissues,  was present in the HST fraction. These data 
suggested  that  MAP  4A,  B,  and  C  can  polymerize  with 
FIGURE 7  Taxol-stabilized microtubules from tissue  extracts.  (A) Gel (7%) and  blot of microtubule pellets  (HPT). (B)  Blot of 
supernatants  remaining after sedimentation of microtubules (HSt). Comparison of immunoblots of HPt and  HSt  probed with 
whole MAP antiserum indicates  that all or portions of MAP 4 are preferentially associated with the microtubule pellet. Small 
portions of the triplet polypeptides and all of band 4 remain in the HSt fraction~. Arrowhead, MAP 4; dash, band 4. 
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though immunologically related to the triplet, does not have 
the ability to bind to taxol-stabilized microtubules. 
DISCUSSION 
Immunoblotting and affinity purification of antibodies have 
shown that MAP 4 is a complex of related polypeptides; the 
complex exists both in  mouse cell lines (25)  and as shown 
here, in a  number of mouse tissues. All three bands of the 
complex co-assemble with  microtubules,  and  all  are  ther- 
mostable.  The 210,000-mol-wt MAP  of HeLa is also ther- 
mostable (41),  and it has been reported this MAP is also a 
triplet of polypeptides (6),  although the antiserum raised to 
this preparation reacted with only a single band on gels. These 
properties of thermostability, complexity, and  similarity in 
molecular weight indicate that MAP 4 and the 210,000-mol- 
wt  HeLa MAP  may be species-specific homologues.  Com- 
plexity in both brain MAP  1 (3) and MAP 2 (1,  3) has also 
recently been described. Low percentage gels resolved each of 
these brain MAP into discrete species. MAP 2 split into two 
bands, both of which were thermostable. MAP  1 split into 
three  bands,  of which  two  (MAP  1A  and  IB) were  more 
sensitive to proteases than MAP  1C. Monoclonal antibodies 
raised to MAP  1 reacted only with MAP  IA, suggesting that 
although the MAP  1 subspecies are functionally related (as- 
sociate with microtubules in vitro), they are structurally dif- 
ferent  polypeptides.  As  discussed  subsequently,  the  subtle 
differences in the polypeptides of the MAP complexes may 
be important in understanding the cell or tissue-specific func- 
tions of these molecules. 
The distribution  of the MAP 4  complex shows variation 
among mouse tissues.  Certain tissues (brain, heart, liver, lung) 
contain  the  MAP  4  triplet,  and this complex co-assembles 
with microtubules derived from extracts of these tissues.  In 
contrast, other tissues (kidney and spleen) contain only band 
4, a polypeptide that does not bind to microtubules in vitro, 
but  that  is  antigenically  related  to  MAP  4.  Some  tissues 
(skeletal muscle), and microtubules derived from them, show 
no  reaction  with  the  antiserum.  Immunoblotting  analyses 
indicated  that the  proteins  reacting with  the  MAP  4  anti- 
serum, especially MAP 4B, C, and band 4, are present in very 
low but reproducible amounts in certain tissues.  As is shown 
in  the  preparations  of microtubules  obtained  from  brain, 
MAP 4 is a very minor component compared with the dom- 
inant brain MAP, MAP 1, and MAP 2 (Fig. 7). Immunoblot- 
ting has shown that the spacing of MAP 4B, C, and band 4 
in brain differs slightly from that in other mouse tissues or 
neuroblastoma  cells.  These  data  suggest  that  the  MAP  4 
complex in brain may be unlike that in other tissues, although 
the MAP 4 polypeptides in all tissues we have examined share 
the properties of immunologic cross-reaction and thermosta- 
bility. 
Our findings on the heterogeneity of the MAP 4 patterns 
in tissues contrast with the results on the distribution of the 
210,000-mol-wt  HeLa  MAP.  Antisera  raised  against  the 
210,000-mol-wt  HeLa MAP  reacted with  a  single band  in 
extracts from human brain, or lysates from continuous hu- 
man or primate cell lines originally derived from liver, kidney, 
muscle, spleen, bladder, connective tissue, and leukocytes (7). 
This difference could reflect particular epitope speciflcities of 
the two antisera used. Alternatively, the MAP distribution in 
cultured cells may not mimic the complexity in distribution 
seen in whole tissues.  Differences have also been found in the 
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distribution of brain MAP  1 and 2 in cultured cells as com- 
pared with tissues.  For example, although initial studies dem- 
onstrated that antibodies raised against high molecular weight 
MAP labeled microtubule networks in cultured cells (12, 29- 
31),  the organization of the two major brain MAP in brain 
tissue has recently been demonstrated to be distinguishable. 
MAP  1 is widespread  in  both  grey and  white  matter (3), 
whereas  MAP  2  is  restricted  to  neuronal  cell  bodies  and 
dendrites (2,  3).  All of these studies suggest  that examining 
the distribution of MAP in adult tissues may be important in 
ultimately understanding how various MAP function in situ. 
For example, our recent immunocytologic analyses demon- 
strate that MAP 4 is very specifically localized to a subset of 
cells within each tissue type (Parysek, L. M., J. B. Wolosewick, 
and J. B. Olmsted, J. Cell Biol., in press). 
In addition to reacting with the MAP 4 protein in brain, 
the whole antiserum used in  some of these  studies labeled 
MAP 1 and, to a much lesser extent, MAP 2 in brain extracts. 
Affinity-purified antibodies to MAP  1 and MAP 4  did not 
cross-react with the nonhomologous antigens, nor with MAP 
2.  These  data  indicate  that  the  three  MAP  in  brain  are 
immunologically  distinct.  Although  proteins  analogous  to 
brain  MAP  1 or MAP 2  were not detected in the  original 
microtubule protein preparations from neuroblastoma cells 
used for immunogen, the presence of antibodies reacting with 
these species indicates that antigenically related proteins must 
be present in these cells.  Wiche et al. (42)  and Bloom et al. 
(4)  have  shown  that  a  high  molecular  weight  protein  in 
neuroblastoma cells cross-reacts with antisera raised to MAP 
1 from brain. However, our data demonstrated that the high 
molecular weight protein in neuroblastoma extracts reacting 
with affinity-purified antibodies to MAP  1 has a lower elec- 
trophoretic mobility than MAP  1 (Fig.  7).  Bloom et al.  (4) 
have also recently shown that monoclonal antibodies to MAP 
1A from brain react with cultured cell  lines derived from a 
number of species and tissue origins; in some of these cells, 
this monoclonal antibody appears to react with closely spaced 
doublets,  or with proteins of higher molecular weight than 
MAP  1A (e.g.,  Chinese hamster ovary cell line).  We found, 
however, no reaction in the MAP 1 region of blots of tissues 
other than brain.  It remains to be determined whether the 
MAP 1 species recognized by our antiserum may be different 
than  that  reacting with  MAP  1A,  or whether  MAP  1A  is 
restricted  in  tissues  as  compared with  cell  lines.  Our  data 
indicate that of the three MAP species in mouse brain recog- 
nized by the whole antiserum, only MAP 4 is prevalent in a 
number of mouse tissues. More detailed analyses of the local- 
ization and expression of each of the components of the MAP 
4 complex, as well as other MAP, should indicate if discrete 
structure-function  correlations for these  proteins in tissues 
can be made. 
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